# Phase 1b Study of DCR-AUD in Healthy Volunteers

> **NCT05845398** · PHASE1 · COMPLETED · sponsor: **Dicerna Pharmaceuticals, Inc., a Novo Nordisk company** · enrollment: 16 (actual)

## Conditions studied

- Alcohol Use Disorder

## Interventions

- **DRUG:** DCR-AUD
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05845398
- **Lead sponsor:** Dicerna Pharmaceuticals, Inc., a Novo Nordisk company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-29
- **Primary completion:** 2023-08-22
- **Final completion:** 2023-08-22
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2026-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05845398

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05845398, "Phase 1b Study of DCR-AUD in Healthy Volunteers". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05845398. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*